With two earlier trials meeting their primary endpoints, Axsome claimed it has the data to support a filing for FDA approval ...

Piper Sandler downgraded Biogen Inc (NASDAQ:BIIB) from “overweight” to “neutral,” given a challenging transition period for ...

Gender differences define how the human brain ages, and telltale biomarkers in the blood may be strongly suggestive of ...

Scientists at Lawson Health Research Institute have been researching how lifestyle factors can affect dementia risk. Surim ...

GSK took center stage last month, forming standout partnerships and alliances across multiple therapeutic areas.

INmune Bio's XPro targets neuroinflammation, showing promising biomarker results in Alzheimer's, with a potential to ...

WATERLOO -- Cedar Valley Clinical Research is seeking participants for a clinical study of an investigational medicine for early Alzheimer's disease. The study is for people who range from having no ...

When we think about dementia, we often think of a person experiencing memory loss and confusion. While it’s true that these ...

To increase awareness and educate, the Central Minnesota Dementia Community Action Network welcomed legislators and community ...

The co-developer of a US-approved drug, Professor Andrew Wilks has formed Synthesis Bioventures to sniff out more winners.